A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients.
Year: 2015
Type: article
Abstract: assay. Therefore, this anti-PSA antibody may serve as a future therapeutic to stimulate functional improvement in multiple sclerosis patients and other neurodegenerative diseases.
Source: PubMed
Institutions: University of Minnesota Rochester, Mayo Clinic
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1933397944
